Drug application
LINEZOLID (LINEZOLID)
Drugs@FDA ANDA 207001 · HQ SPCLT PHARMA
Key facts
| Drug name | LINEZOLID |
|---|---|
| Active ingredients | LINEZOLID |
| Application type | ANDA |
| Application number | 207001 |
| Company | HQ SPCLT PHARMA |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 200MG/100ML (2MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jul 7, 2017 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.